Profiel
Chun Chun Tang is currently a Director at StemCyte, Inc. since 2014.
Prior to this, Mr. Tang was the Chairman, General Manager & Spokesman at Fountain Biopharma, Inc.
Actieve functies van Chun Chun Tang
| Bedrijven | Functie | Begin |
|---|---|---|
StemCyte, Inc.
 StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Directeur/Bestuurslid | 17-04-2014 |
Eerdere bekende functies van Chun Chun Tang
| Bedrijven | Functie | Einde |
|---|---|---|
| FOUNTAIN BIOPHARMA INC | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
StemCyte, Inc.
StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Health Technology |
Fountain Biopharma, Inc.
 Fountain Biopharma, Inc. Pharmaceuticals: OtherHealth Technology Fountain Biopharma, Inc. engages in the research, development and sales of antibody drugs. Its products include anti-allergic monoclonal antibody drugs, monoclonal antibody drugs, immune checkpoint aptamer drugs, anti-lag-3 immunological checkpoint aptamer drugs and anti-tumor stem cell labeled antibody drugs. The company was founded on November 25, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
